Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The variable manifestations of disease in pyruvate kinase deficiency and their management

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Sonja Zweegman
  • Claudia A M Stege
  • Einar Haukas
  • Fredrik H Schjesvold
  • Mark-David Levin
  • Anders Waage
  • Rineke B L Leys
  • Saskia K Klein
  • Damian Szatkowski
  • Per Axelsson
  • Trung Hieu Do
  • Dorota Knut-Bojanowska
  • Ellen van der Spek
  • Asta Svirskaite
  • Anja Klostergaard
  • Morten Salomo
  • Celine Blimark
  • Paula F Ypma
  • Ulf-Henrik Mellqvist
  • Pino J Poddighe
  • Marian Stevens-Kroef
  • Niels W C J van de Donk
  • Pieter Sonneveld
  • Markus Hansson
  • Bronno van der Holt
  • Niels Abildgaard
Vis graf over relationer
OriginalsprogEngelsk
TidsskriftHaematologica
Vol/bind105
Udgave nummer12
Sider (fra-til)2879-2882
Antal sider4
ISSN0390-6078
DOI
StatusUdgivet - dec. 2020

ID: 62109007